Virology, Epidemiology, Pathogenesis, and Control of COVID-19

被引：945

作者：

Jin, Yuefei ^{[1
]}

Yang, Haiyan ^{[1
]}

Ji, Wangquan ^{[1
]}

Wu, Weidong ^{[2
]}

Chen, Shuaiyin ^{[1
]}

Zhang, Weiguo ^{[1
,3
]}

Duan, Guangcai ^{[1
]}

机构：

[1] Zhengzhou Univ, Dept Epidemiol, Coll Publ Hlth, Zhengzhou 450001, Peoples R China

[2] Xinxiang Med Univ, Sch Publ Hlth, Xinxiang 453003, Henan, Peoples R China

[3] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA

来源：

VIRUSES-BASEL | 2020年 / 12卷 / 04期

基金：

中国博士后科学基金; 中国国家自然科学基金;

关键词：

SARS-CoV-2; COVID-19; epidemiology; pathogenesis; therapeutics; ACUTE RESPIRATORY SYNDROME; SARS-CORONAVIRUS; INFECTION; LOPINAVIR/RITONAVIR; REPLICATION; CHLOROQUINE; COMBINATION; RIBAVIRIN; ANTIBODY; INHIBIT;

D O I：

10.3390/v12040372

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China has been brought to global attention and declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Scientific advancements since the pandemic of severe acute respiratory syndrome (SARS) in 2002 similar to 2003 and Middle East respiratory syndrome (MERS) in 2012 have accelerated our understanding of the epidemiology and pathogenesis of SARS-CoV-2 and the development of therapeutics to treat viral infection. As no specific therapeutics and vaccines are available for disease control, the epidemic of COVID-19 is posing a great threat for global public health. To provide a comprehensive summary to public health authorities and potential readers worldwide, we detail the present understanding of COVID-19 and introduce the current state of development of measures in this review.

引用

页数：17

共 86 条

[1]

Abdelmageed M I., 2020, bioRxiv

[2] Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease [J].

Agostini, Maria L. ;

Andres, Erica L. ;

Sims, Amy C. ;

Graham, Rachel L. ;

Sheahan, Timothy P. ;

Lu, Xiaotao ;

Smith, Everett Clinton ;

Case, James Brett ;

Feng, Joy Y. ;

Jordan, Robert ;

Ray, Adrian S. ;

Cihlar, Tomas ;

Siegel, Dustin ;

Mackman, Richard L. ;

Clarke, Michael O. ;

Baric, Ralph S. ;

Denison, Mark R. .

MBIO, 2018, 9 (02)

[3]

[Anonymous], Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

[4]

Bao L., 2020, BIORXIV, P990226, DOI [DOI 10.1101/2020.03.13.990226, DOI 10.1101/2020.03.13.990226V2, 10.1101/2020.03.13.990226]

[5]

Chan K. S., 2003, Hong Kong Medical Journal, V9, P399

[6] In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds [J].

Chen, F ;

Chan, KH ;

Jiang, Y ;

Kao, RYT ;

Lu, HT ;

Fan, KW ;

Cheng, VCC ;

Tsui, WHW ;

Hung, IFN ;

Lee, TSW ;

Guan, Y ;

Peiris, JSM ;

Yuen, KY .

JOURNAL OF CLINICAL VIROLOGY, 2004, 31 (01) :69-75

[7]

Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005

[8]

China Food and Drug Administration, CHIN FOOD DRUG ADM E

[9] One month of the novel coronavirus 2019 outbreak: Is it still a threat? [J].

Apu Chowdhury ;

Nabila Jahan ;

Sicen Wang .

VirusDisease, 2020, 31 (2) :174-178

[10] Hosts and Sources of Endemic Human Coronaviruses [J].

Corman, Victor M. ;

Muth, Doreen ;

Niemeyer, Daniela ;

Drosten, Christian .

ADVANCES IN VIRUS RESEARCH, VOL 100, 2018, 100 :163-188

← 1 2 3 4 5 6 7 8 9 →